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It has become increasingly apparent that subclasses of thymus-derived lymphocytes 
suppressively regulate  cell-mediated immune  phenomena such  as  graft-versus-host 
reaction  (GvH) 1 (1,  2),  cytotoxic allograft response  (3),  in vitro mixed lymphocyte 
reaction (MLR)  (4), and contact delayed hypersensitivity (5). Recently, we reported 
on the T-T-cell interaction in delayed hypersensitivity (DH) response in mice induced 
by  immunization  with  methylated human  serum  albumin  (MHSA)  in  complete 
Freund's adjuvant (CFA), as revealed by cell transfer study and adult thymectomy 
(6). We suggested that the suppressor T cells regulated the DH in the induction stage. 
The suppressor activity was detected in such conventionally immunized mice, prom- 
inent in the young mouse thymus cells, but rare in the old mouse thymus cells or 
peripheral lymphocytes (6). 
On the other hand, DH seems to be regulated by humoral antibodies. There is an 
apparent  inverse relationship between induction of humoral antibody response and 
DH  reactivity  (7,  8).  Moreover,  DH  induction is  inhibited by  antibodies  such  as 
gammal-eontrasensitizing antibodies (9,  10). Pretreatment of guinea pigs with cyclo- 
phosphamide (CY), an alkylating drug, was also reported to increase DH intensity 
associated with a reduction in gammas-antibody production (11). Recently, treatment 
of animals with CY has been a popular method of investigating the suppressive role 
of humoral antibodies in DH, for this drug has been considered to affect B cells rather 
selectively (12-14). 
In our preliminary work (15), we attempted to determine the effect of CY on the 
DH to MHSA. The DH was augmented by pretreatment of mice with CY, and it was 
suggested that augmentation of DH was attributed to damage of the suppressor T 
cells but not the B cells. The present work reconfirms our previous suggestion and an 
analysis is made of the cellular regulation involved in the mouse DH with application 
of CY. 
* Requests for reprints should be sent to: Department of Thoracic Surgery, Tenri Hospital, Tenri (632) 
Japan. 
x Abbreviations used in this paper: CFA, complete Freund's adjuvant; CY, cyclophosphamide;  DH, delayed 
hypersensitivity;  FPR,  footpad  reaction; GvH,  graft-versus-host  reaction; MHSA,  methylated human 
serum albumin; MLR, mixed lymphocyte reaction; PBS, phosphate-buffered  saline, SRBC, sheep eryth- 
roc~,tes. 
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Materials  and Methods 
Mice.  Inbred  C57BL/6  mice  were  used  throughout.  C57BL/6J  mice  were  raised  and 
maintained  by brother  and  sister  mating  in  the  animal  house  of Chest  Disease  Research 
Institute, Kyoto University. C57BL/6Cr mice were purchased from the Experimental Animal 
Cooperative Association of Shizuoka (Hamamatsu), and C57BL/6N were purchased from the 
Charles River Japan Co., Ltd. (Atsugi). 
Antigen.  Human  serum  albumin  four times  crystailyzed was obtained  from  Nutritional 
Biochemicals Co. (Cleveland, Ohio). MHSA was prepared by the methanol-hydrochloric acid 
method described by Crowle et al. (7). 
Preparation of Cell Suspension.  Suspensions of thymus, spleen, and bone marrow ceils were 
prepared according to the method described elsewhere (16). 
Thymectomy.  Adult thymectomy was performed at  various ages according to the method 
described previously (16). 
Splenectomy.  Mice  were  anesthetized  with  pentobarbital  sodium  given  intraperitoneally. 
After skin incision on the left side of the abdomen, laparotomy was performed by incising the 
abdominal muscles and peritoneum with scissors. The spleen was grasped by two forceps. While 
pressing branches of the splenic artery and vein with one forceps, the spleen was removed by 
tearing off from those vessels with the other forceps.  Heated forceps were used for coagulation 
of the torn vessels. The abdominal wall  and  the skin wounds were closed with  silk  thread, 
respectively. 
Sensitization.  Sensitization for footpad DH assay was carried out by subcutaneous injection 
into the left hind footpad with 0.05 ml of emulsion consisting of an equal vol of 0.5% MHSA 
solution in phosphate-buffered saline (PBS), pH 7. I, and CFA. 
Footpad Assay  for DH.  Footpad measurement was made according to the method described 
previously  (t7).  Briefly,  the  difference  in  footpad  thickness  at  24  h  after  and just  before 
challenge was measured and expressed as footpad reaction (FPR) in 0.1-mm units. Challenge 
with  0.02  ml  of 0.1%  MHSA solution  in  PBS  was  routinely  performed  on  11-13  d  after 
sensitization. 
CY Treatment.  Mice were given CY treatment  intraperitoneally,  (Endoxan, Shionogi Co., 
Osaka), 150 mg/kg body weight, before sensitization. The interval of 4 d between CY treatment 
and sensitization was most commonly adopted. A reproducible enhancement occurred at this 
dose  and  interval  (data  not  shown).  In  some  experiments,  CY  treatment  was  made  after 
sensitization. 
Results 
Age-Related  Changes of DH to  MHSA  and  Thymus  Weight  in  Normal and CY-Treated 
C57BL/6  Mice  (Fig.  1).  In  normal  C57BL/6J  mice,  the  level  of DH  to  MHSA 
increased  with  increase  in  age of the  mice from 5  wk to 8  mo,  a  result  which  was 
consistent with our previous data (6). Pretreatment  of young mice with CY 4 d before 
sensitization enhanced the DH markedly, whereas the pretreatment of mice aged 6 or 
8  mo did  not.  As a  result,  the level of DH  in  variously aged mice which had  been 
given CY was much the same, and also similar  to the level seen in nontreated  aged 
mice. 
Decrease in thymus weight was apparent  up  to 6  mo of age in  nontreated  mice. 
Hence,  the  upper age limits  in  CY-enhancing phenomenon  and  in  drastic  thymus 
involution appeared  to be much the same.  The effect of CY on the DH in C57BL/ 
6Cr mice was somewhat decreased but comparable to that in C57BL/6J mice. 
Effect of Antigen Dose on the DH in Normal and CY-Treated Mice.  Both young adult  (3 
mo) and old (10 mo) mice were sensitized with varying doses of MHSA, followed by 
challenge 12 d later. FPR at 24, 48, and 96 h was measured  (Table I). In young mice, 
a  slight FPR at 24 h  was seen with 5, 25, and  125 #g MHSA. With 625 #g MHSA, a 
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Fro.  1.  Age-associated changes of DH to MHSA in normal (dotted column) or CY treated (open 
column) mice, and thymus weight in normal (solid line) or CY treated (broken  line) mice. Mice 
were given CY,  150  mg/kg i.p.,  4 d  before sensitization.  Each group included four to six mice. 
Vertical bars are standard errors of the means. W, weeks; m, months. 
TABLE  I 
Dose-Response of DH to MHSA and the Effect of CY 
Age  CY  MHSA 
FPR after challenge on 12th d 




btg  h 
-  5  3.0  ::t: 0.5  2.0  +  0.3  1.0  +  0.3 
-  25  4.0  +  0.7  2.8  ::1: 0.4  1.2  ::h  0.2 
--  125  3.8  ::t: 0.4  2.6 +  0.7  1.4 :1: 0.4 
--  625  7.4  +  1.7  3.8  ::t: 0.8  1.0 +  0.4 
+  25  11.8 ::t: 2.6  10.8 +  3.1  1.0 :1: 0.4 
+  625  10.3 +  2.7  4.3  +  1.6  1.0  ::1: 0.4 
--  5  9.3  4-  2.4  8.1  +  2.4  3.9  "4-  1.5 
--  25  5.3  ::t:  2.1  6.5  :1:  1.8  1.5  ::lz 0.8 
--  125  15.8 +  3.1  15.3  ::t: 4.7  6.5  :1:  2.5 
--  625  15.0 +  1.3  8.5  +  1.8  2.5  ::1: 0.7 
Female C57BL/6Cr mice were sensitized with varying doses of MHSA in CFA. 
mg/kg i.p., 4 d before sensitization.  Each group included four to seven mice. 
* Mean 3=  standard error. 
Mice were given CY,  150 
FPR  was seen at  48  h.  When  CY  was given 4  d  before sensitization in such young 
mice, FPR at 24 h  was enhanced to the same level in lower and higher-dosed  sensitized 
mice.  However,  CY  did  not  block  a  decline of FPR  at  48  h  in  the  higher-dosed 
sensitized mice. 
In old mice, the optimal sensitizing dose of MHSA  appeared to be 125-625 #g. The 
level of DH  reaction was higher in old mice. The  decline of DH  reaction at  48  h  in 
old mice sensitized with 625 #g MHSA  was also marked. MITSUOKA ET AL.  1021 
TABLE II 
Suppressive Effect of Thymocytes on the Enhanced DH by Cyclophosphamide 
Treatment 
CY  Thymocytes  No.  DH on day I 1 
-  -  5  2.8  ±  1.0 
-  +  6  3.0  ±  0.9 
+  -  5  9.2 ±  1.7 
+  +  6  3.5 ±  1.2 
Male G57BL/6Cr mice aged 2.5 mo were given CY, 150 mg/kg i.p., on day 
-4, and 2.5 ×  107 thymus cells were transferred from normal syngeneic  young 
mice on day -2 of sensitization. 
From  results  in  Fig.  1 and  Table  I,  it  appears  that  DH  reactivity  assumes  the 
pattern seen in old mice when young mice are treated with CY. 
Suppressive Effect of  Normal Thymocytes on the Enhanced DH in Mice Pretreated  with C Y.  In 
our previous work (6), we suggested that the DH induction  is strongly regulated by 
suppressor T  cells  in  young C57BL/6  mice but  that  the  suppressor T-cell activity 
diminishes in aged animals. It is possible, hence, that enhancement of DH due to CY 
treatment of these young mice is attributed to elimination of such suppressor activity. 
For elucidation, young mice were given CY followed by a  normal young thymoeyte 
transfer before sensitization. As shown in Table II, administration of normal thymo- 
cytes did eliminate the DH enhancing effect of CY treatment. Thus, our preliminary 
suggestion (15)  was confirmed. 
Effect of Thymocytes or Splenocytes Transfer  from Normal or CY-Treated  Young Mice on the 
Enhanced DH in CY-Treated Mice.  To determine whether there is a difference in T-cell 
(or precursor)  activities, effector or suppressor, between T-axis cells  in  the  thymus 
stage of nontreated  and CY-treated mice, donor cells were also obtained from CY- 
treated mice. As shown in Fig. 2, enhanced DH due to CY treatment was suppressed 
by normal thymocytes but not by thymocytes from mice which had been given CY 7 
or 13 d before the cell transfer. Thymocytes from mice treated with CY 7 d previously 
further enhanced the DH. Spleen cells never suppressed the DH reaction, and normal 
spleen cells enhanced  the DH in this experiment. These data suggest that there are 
different  subpopulations  of thymocytes and  that  lymphocytes in  the  nonsensitized 
mouse spleen bear little, if any, suppressor activity in DH. 
Suppression of DH by  Treatment with  CY after Sensitization and  its  Reconstitution with 
Lymphoid Cells.  We previously found  that  treatment of mice with CY  at  4  or 9  d 
after sensitization suppressed the DH on day  12 of sensitization  (15). To determine 
what cell populations were injured by post-treatment with CY, mice were given CY 
6  d  after  sensitization  (5  d  before  challenge)  followed  by cell  transfer  of normal 
lymphoid cells  1 d  thereafter  (4  d  before challenge)  (Table III). Bone marrow cells 
alone  or  thymus  cells  alone  could  not  restore  the  DH  reactivity.  However,  with 
application  of both  of these  cells,  the  mice  were  rendered  full  reactivity  of DH 
response, as the level of DH was comparable to that of DH on day 4 in normal mice 
(16). 
Effect  of Cy  Treatment on  DH  in  Different Time  Schedules for  DH  Induction.  Our 
preceding data indicate the age-dependent difference in the kinetics of DH reactivity 
after sensitization;  in old C57BL/6 mice, the DH reactivity showed its peak during 1022  CYCLOPHOSPHAMIDE  ELIMINATES  SUPPRESSOR  T  CELLS 
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F~c.  2.  Effect of cell transfer on the enhanced DH in CY treated mice. Recipient mice were treated 
with CY 4 d before sensitization. 1 d after CY treatment, the mice were transferred with 2  ×  107 
thymocytes (hatched column) or 5  ×  l0  T splenocytes (dotted column) from normal mice or mice 
which had been treated with CY 7 d or 13 d before cell transfer, as indicated above. Two control 
groups,  nontreated and CY-treated  mice without cell  transfer are  shown as open columns.  All 
animals used in this experiment were male C57BL/6Cr mice aged 2.5 mo. Each group included five 
to seven mice. 
TASX.E  III 
Reconstitution with Lymphoid Cells of Immunodepressed Mice by Treatment 
with Cyclophosphamide 
CY  Cells transferred  No.  DH on day  11 
-  No  5  10.6  ±  2.5 
+  No  5  0.8 ±  0.6 
+  Marrow cells  6  1.8 ±  0.6 
+  Thymus cells  5  2.4  ±  0.2 
+  Marrow cells and  6  5.2  ±  1.0 
thymus cells 
Male C57BL/6J mice aged 5 mo were given CY,  150 mg/kg i.p.,  6 d  after 
sensitization and 1 ×  107 bone marrow cells and 2.5  ×  107 thymus cells from 
normal syngeneic mice were given 2 d thereafter. 
12-16  d  after sensitization, gradually  decreasing in its reactivity afterward  (16), and 
in young  C57BL/6  mice, the peak  DH  reactivity was  seen 8-12  d  after sensitization 
and  was  followed  by  a  rapid  loss  of  reactivity  (A.  Mitsuoka,  unpublished  data). 
Earlier  peak  DH  reactivity  in  young  mice  might  also  be  the  result  of more  potent 
regulation  by a  suppressor mechanism  in young  mice. 
For  clarification,  the  effect  of  CY  on  DH  was  investigated  in  different  time 
schedules.  In 8-mo-old  mice, DH  reactivity was  generally high, even on day  16 after 
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Fro.  3.  Kinetics of DH reactivity on various days after sensitization in normal (open column) or 
CY-treated (hatched column) mice of various ages. The timing of CY treatment is indicated on the 
left shoulder of the hatched column, where minus means before, and plus means after sensitization. 
Each group included five animals. 
group of mice (Fig.  3 A). In young mice (3 mo), DH reactivity was less intense and 
the peak response was seen on day 8. When CY was given to these mice, the DH on 
day  12  or  13  was  markedly  enhanced.  The  DH  on  day  8  was,  however,  neither 
enhanced nor suppressed with CY (Fig. 3 B and 3 C). 
Influence of Previous Surgical Treatments of Mice on the DH in Nontreated and CY- Treated 
Mice.  The  foregoing data  indicate  that  CY  treatment  of mice damages  not  only 
suppressor T  cells but effector T  cells and bone marrow-derived monocytes. Recovery 
from the damag  e of effector T  cells and  monocytes is considered  to be more rapid 
and/or more complete than that  of suppressor T  cells.  If this is the case, one of the 
problems is the location of the recovery site of effector T  cells in CY-treated young 
mice. Thus, mice were surgically prepared before CY treatment  (Table VI). 
Mice which had been thymectomized 5 wk before showed a somewhat lesser degree 
of DH reaction as compared with intact mice. The difference was not significant. CY 
treatment before sensitization enhanced the DH in intact mice but not thymectomized 
ones  (Table  IV).  As  shown  in  Table  V,  splenectomy  or  sham  operation  did  not 
significantly affect the DH level. CY treatment enhanced the DH in both intact and 
splenectomized  mice.  Similar  results  are  shown  in  Table  VI,  in  which  previously 
splenectomized mice but not thymectomized mice given CY postoperatively exhibited 
a  more intense DH than the nontreated mice. 
Discussion 
Suppressor T  cells  involved  in  DH  against  MHSA  in  mice  decrease  in  activity 
through  aging  processes  linked  with  physiological  involution  of  the  thymus  (6). 
Results of CY treatment before sensitization, in relation to aging, indicate the strong 1024  CYCLOPHOSPHAMIDE  ELIMINATES  SUPPRESSOR T  CELLS 
TABLE  IV 
Effect of Cyclophosphamide on the DH to MHSA in Intact  or Thymectomized 
Mice 
CY  ThX  DH on day 12  Thymus weight 
--  --  11.6  :t:  3.2 
-3d  --  t4.6  +  2.1 
-15 d  --  22.3 ±  2.3 
-30 d  --  16.3 i  0.3 
--  -5  wk  7.3  ±  2.9 
-3 d  -5 wk  8.6 ±  2.3 
-15 d  -5 wk  10.3 ±  0.5 




Male C57BL/6Cr mice were thymectomized 5 wk before and then given CY, 
150 mg/kg i.p., 3-30 d before sensitization as indicated. Age of mice was 4 mo 
at sensitization.  Each group included four to five animals. 
TABLE  V 
Effect of Cyclophosphamide on the DH to MHSA in Intact or Splenectomized 
Mice 
CY  SpX  DH on day 13  No. 
No  No  2.8:1:0.9  5 
Yes  No  12.8 ±  2.0  6 
No  Yes  3.4 +  1.0  5 
Yes  Yes  16.4 ±  1.6  5 
No  No*  4.3  +  1.2  3 
Female C57BL/6N mice were sensitized at the age of 2.5 mo. Splenectomy 
was performed 2 wk before, and CY was given 4 d before sensitization. 
* Sham operation. 
TABLE  VI 
Effect of Thymectomy or Splenectomy on the DH to MHSA in Mice Treated 
with CY 
CY  Surgical  treat-  No.  DH on day 12 
ment 
-  --  4  2.3  +  0.4 
+  --  4  16.8 _+  1.1 
+  SpX  3  10.7 ±  4.4 
+  ThX  6  2.5  +  0.9 
Male C57BL/6Cr mice aged 2.5 mo were splenectomized or thymectomized 
on day -I1, and then given CY,  150 mg/kg i.p., on day -4 of sensitization. 
suppressive regulation of DH working in normal young C57BL mice, and the absence 
of regulation in CY-treated mice as well as in nontreated-aged ones (Fig.  1).  This DH 
enhancement  with CY  was more apparent  at  the lower dose sensitization (Table  I). 
Moreover, the antigen, MHSA,  is one which does not  induce a  detectable antibody 
production  (17).  Therefore, it  is unlikely that  this DH  enhancement  with CY  is due 
to inhibition of B  cells which modulate  DH,  as was suggested in  other experimental 
systems (11,  18,  19). 
In fact, enhancement  of DH  with CY was eliminated by the transfer of thymocytes 
from normal syngeneic young mice, thereby suggesting the involvement of T  cells in MITSUOKA ET AL.  1025 
suppressive regulation of DH  (Table II).  Further studies with cell transfer (Fig.  2) 
indicate that, in the thymus stage, T-axis lymphocytes are differentiated into distinct 
suhpopulations  for  later  further  differentiation in  the  peripheral  organs.  Spleen- 
localized cells have no suppressive effect on the DH, which is also consistent with our 
previous observations (6, 15). 
Our results suggest that DH enhancement with CY can be attributed to elimination 
of suppressor T  cells. The alternative interpretation, however, is that  the apparent 
enhancement is solely a reflection of delayed kinetics of DH reactivity because of poor 
and slow sensitization with antigen by remaining lymphoid cells after CY-induced 
damage. A  drastic damage of these cells after CY treatment is shown in Table III, 
which is consistent with findings of others (19,  20).  Results in Fig.  3 eliminate the 
possibility of the alternative interpretation. Effect of CY treatment is not the sole shift 
of the  kinetics  curve  of DH  reaction  but  rather  both  increase  in  intensity  and 
persistency of DH reactivity. This means increase in the integral calculus of the time- 
response curve, indicating the net increased activity of effectors. 
The enhancement of DH with CY requires sufficient recovery of effector T  cells 
and macrophages from damage induced by CY treatment. It can be postulated that 
in  such  a  situation,  sensitization  of effector T  cells  might  effectively occur in  the 
absence of suppressor T  cells whose recovery appears to be more limited. Experiments 
of thymectomy shortly before sensitization show that overshooting recovery site for 
effector T  cells is mainly the thymus, and splenectomy does not significantly affect 
the DH  (Table IV). The relatively lesser importance of the spleen and  the greater 
importance of the thymus in the development of DH is, however, limited to the young 
(A.  Mitsuoka,  data  to be published).  We previously reported that  thymectomy of 
young C57BL mice at  appropriate intervals before sensitization causes a  profound 
enhancement of DH, suggesting the short life-span character of suppressor T cells (6). 
Hence, in  the young, outflux of precursor T  effector cells from the  thymus to the 
peripheral organs appears to be continuous. At the same time, release of ~uppressor 
cell precursors from the thymus is probably required for the maintenance of homeo- 
stasis.  The  suggestive  central  regulation  in  cell-mediated  immunity  appears  most 
apparent in C57BL mice.  ~ 
Recently, an increasing number of papers have dealt with elimination of suppressor 
cells with CY in enhancement of contact DH in guinea pigs (21) or in mice (22,  23). 
In these systems in mice  (22,  23), two different antigen-specific suppressor cells are 
involved. One has  the T-cell nature,  is  induced  by intravenous pretreatment  with 
antigen, and is resistant to CY. The other does not have the T-cell nature, is induced 
with supraoptimal dose of the antigen and in the latter period after sensitization, and 
sensitive to CY. These seem to be categorized as a peripheral regulation. 
As to the peripheral regulation, we found antigen-specific suppressor T  cells in DH 
to  MHSA,  and  these  cells  are  generated  by  pretreatment  with  the  antigen  from 
peripherally  localized  precursor  cells  with  a  long  life-span,  and  are  nylon-wool 
adherent and resistant to CY (S. Morikawa et al., data to be published). 
Another  example  is  that  the  DH  induced  by  intravenous  sensitization  with  a 
supraoptimal dose of sheep erythrocytes (SRBC) is shown to be enhanced with CY, 
and this was attributed to selective inhibition of B cells with CY (18). More recently, 
S. Morikawa et al. Manuscript in preparation. 1026  CYCLOPHOSPHAMIDE  ELIMINATES SUPPRESSOR  T  CELLS 
a  similar  phenomenon  was  reported  to  be  because  of elimination  of the  antigen- 
specific  suppressor  T  cells  localized  in  the  spleen  (24-26).  Even  if such  DH  to 
heterologous erythrocytes is substantially of the tuberculin type, sensitization kinetics 
and the regulatory mechanisms of this DH seem different from those of DH to MHSA 
as previously discussed (27). Enhancement of DH to SRBC with CY occurs only at a 
supraoptimal dosed antigen sensitization (18,  26). This is also the case in contact DH 
as was shown and discussed by Sy et al. (23).  On the other hand, the DH induced by 
an optimal dose of SRBC is drastically impaired if splenectomy is performed before 
sensitization  (28)  or  before challenge  (29).  Such  is  not  the  case  in  DH to  MHSA 
(Tables I and V), and our findings are consistent with other reports dealing with DH 
induced  by sensitization  with  the  help  of CFA  (30,  31).  In  the ease of the  DH  to 
SRBC,  CY  treatment  of mice, as well  as  splenectomy, is  considered  to result  in  a 
markedly decreased  capacity of sensitization.  As  the  result,  if the actual  processed 
antigen dose is taken into account, administration of high dose SRBC in such treated 
mice may be equivalent to that of low dose SRBC in intact mice, hence induction of 
feedback regulation by B ceils (18) or suppressor T  cells (26)  being indeed minimum. 
Finally,  suppressor  T  cells  which  are  generated  without  corresponding  antigen 
pretreatment are reportedly involved in in vivo generation of antigen-specific cytotoxic 
T  cells  to  allogeneic  or  hapten-conjugated  syngeneic  lymphocytes  (32).  A  similar 
regulation to that involved in DH to MHSA reported herein may play a  role in this 
case, 
Suppressor T  cells in the regulation of experimental autoimmune disease (33)  may 
be another example of the implication of the physiological role of these cells. 
Summary 
Effect of treatment of mice with cyclophosphamide (CY) on the delayed hypersen- 
sitivity (DH) response was investigated in C57BL/6 mice. DH to methylated human 
serum albumin (MHSA) could be enhanced with CY in young mice but not in aged 
ones. DH enhancement with CY appeared to be due to elimination of suppressor T 
cells involved in DH. Effector T  cells were also sensitive to CY, the damaging effect 
of CY on these latter cells was, however, transient  suggesting the rapid recovery of 
effector T  cells. The overshooting recovery of the effector T  cells required the presence 
of the thymus. 
It is more probably that there are at least two distinct subpopulations of T  ceils in 
DH, effector T  cells, and suppressor T  cells. The distinction is already apparent in the 
thymus stage. The suppressor T  cells, categorized as a  central regulator, seem to be 
antigen  nonspecific  and  regulate  more  effectively  the  DH  in  young  mice,  thus 
physiological role of these cells in age-associated immune alterations is implicated. 
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